Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1968 1
1969 1
1972 1
1975 2
1978 3
1983 1
1985 2
1986 1
1988 1
1990 1
1991 2
1992 2
1993 2
1994 3
1995 1
1996 1
1997 5
1998 5
1999 6
2000 7
2001 8
2002 10
2003 2
2004 10
2005 5
2006 5
2007 14
2008 10
2009 18
2010 24
2011 38
2012 45
2013 39
2014 49
2015 52
2016 76
2017 73
2018 84
2019 76
2020 112
2021 141
2022 160
2023 140
2024 125
2025 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,267 results

Results by year

Filters applied: . Clear all
Page 1
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial.
Fleischmann R, Pangan AL, Song IH, Mysler E, Bessette L, Peterfy C, Durez P, Ostor AJ, Li Y, Zhou Y, Othman AA, Genovese MC. Fleischmann R, et al. Among authors: othman aa. Arthritis Rheumatol. 2019 Nov;71(11):1788-1800. doi: 10.1002/art.41032. Epub 2019 Aug 28. Arthritis Rheumatol. 2019. PMID: 31287230 Clinical Trial.
Parasite-bacteria interrelationship.
Ashour DS, Othman AA. Ashour DS, et al. Among authors: othman aa. Parasitol Res. 2020 Oct;119(10):3145-3164. doi: 10.1007/s00436-020-06804-2. Epub 2020 Aug 4. Parasitol Res. 2020. PMID: 32748037 Review.
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study.
Smolen JS, Pangan AL, Emery P, Rigby W, Tanaka Y, Vargas JI, Zhang Y, Damjanov N, Friedman A, Othman AA, Camp HS, Cohen S. Smolen JS, et al. Among authors: othman aa. Lancet. 2019 Jun 8;393(10188):2303-2311. doi: 10.1016/S0140-6736(19)30419-2. Epub 2019 May 23. Lancet. 2019. PMID: 31130260 Free article. Clinical Trial.
Imaging of Cholangiocarcinoma.
Olthof SC, Othman A, Clasen S, Schraml C, Nikolaou K, Bongers M. Olthof SC, et al. Among authors: othman a. Visc Med. 2016 Dec;32(6):402-410. doi: 10.1159/000453009. Epub 2016 Dec 6. Visc Med. 2016. PMID: 28229074 Free PMC article. Review.
A Primary Care-Based Weight Navigation Program.
Griauzde DH, Turner CD, Othman A, Oshman L, Gabison J, Arizaca-Dileo PK, Walford E, Henderson J, Beckius D, Lee JM, Carter EW, Dallas C, Herrera-Theut K, Richardson CR, Kullgren JT, Piatt G, Heisler M, Kraftson A. Griauzde DH, et al. Among authors: othman a. JAMA Netw Open. 2024 May 1;7(5):e2412192. doi: 10.1001/jamanetworkopen.2024.12192. JAMA Netw Open. 2024. PMID: 38771575 Free PMC article.
Highlight report: hepatotoxicity prediction with Hep3B cells.
Hammad S, Ellethy T, Othman A, Mahmoud HYAH. Hammad S, et al. Among authors: othman a. Arch Toxicol. 2018 Jul;92(7):2403. doi: 10.1007/s00204-018-2242-8. Epub 2018 Jun 11. Arch Toxicol. 2018. PMID: 29936629 No abstract available.
The reactive pyruvate metabolite dimethylglyoxal mediates neurological consequences of diabetes.
Rhein S, Costalunga R, Inderhees J, Gürtzgen T, Faupel TC, Shaheryar Z, Arrulo Pereira A, Othman A, Begemann K, Binder S, Stölting I, Dorta V, Nawroth PP, Fleming T, Oexle K, Prevot V, Nogueiras R, Meyhöfer S, Meyhöfer SM, Schwaninger M. Rhein S, et al. Among authors: othman a. Nat Commun. 2024 Jul 10;15(1):5745. doi: 10.1038/s41467-024-50089-3. Nat Commun. 2024. PMID: 38987239 Free PMC article.
1,267 results